Effects of soybean beta-conglycinin on body fat ratio and serum lipid levels in healthy volunteers of female university students
The changes in body fat ratio and serum lipids induced by the ingestion of β-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of β-conglycinin differed between students with a baseline body fat ratio over 25%...
Saved in:
| Published in | Journal of Nutritional Science and Vitaminology Vol. 50; no. 1; pp. 26 - 31 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Tokyo
Center for Academic Publications Japan
01.02.2004
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The changes in body fat ratio and serum lipids induced by the ingestion of β-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of β-conglycinin differed between students with a baseline body fat ratio over 25% and those less than 25%. In the former group, the ingestion of β-conglycinin suppressed the increase in body fat ratio. Moreover the six sub-jects who had a high total cholesterol level (5.72 mmol/L or higher) tended to have reduced levels of serum triglyceride, free fatty acid, total cholesterol and lipoprotein (a) after the ingestion of β-conglycinin, although those levels did not change significantly. The number of subjects was only six, therefore it was inferred that significant changes were not observed. Thus, ingestion of soybean β-conglycinin suppressed the increase in body fat ratio in indi-viduals with a high baseline body fat ratio and reduced relatively high serum levels of lipids. Those results suggest that if soybean β-conglycinin is ingested continuously (5g daily), it will be effective in keeping body fat ratio and serum lipid levels normal and eliminating excessive lipids from the body |
|---|---|
| AbstractList | The changes in body fat ratio and serum lipids induced by the ingestion of beta-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of beta-conglycinin differed between students with a baseline body fat ratio over 25% and those less than 25%. In the former group, the ingestion of beta-conglycinin suppressed the increase in body fat ratio. Moreover the six subjects who had a high total cholesterol level (5.72 mmol/L or higher) tended to have reduced levels of serum triglyceride, free fatty acid, total cholesterol and lipoprotein (a) after the ingestion of beta-conglycinin, although those levels did not change significantly. The number of subjects was only six, therefore it was inferred that significant changes were not observed. Thus, ingestion of soybean beta-conglycinin suppressed the increase in body fat ratio in individuals with a high baseline body fat ratio and reduced relatively high serum levels of lipids. Those results suggest that if soybean beta-conglycinin is ingested continuously (5 g daily), it will be effective in keeping body fat ratio and serum lipid levels normal and eliminating excessive lipids from the body.The changes in body fat ratio and serum lipids induced by the ingestion of beta-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of beta-conglycinin differed between students with a baseline body fat ratio over 25% and those less than 25%. In the former group, the ingestion of beta-conglycinin suppressed the increase in body fat ratio. Moreover the six subjects who had a high total cholesterol level (5.72 mmol/L or higher) tended to have reduced levels of serum triglyceride, free fatty acid, total cholesterol and lipoprotein (a) after the ingestion of beta-conglycinin, although those levels did not change significantly. The number of subjects was only six, therefore it was inferred that significant changes were not observed. Thus, ingestion of soybean beta-conglycinin suppressed the increase in body fat ratio in individuals with a high baseline body fat ratio and reduced relatively high serum levels of lipids. Those results suggest that if soybean beta-conglycinin is ingested continuously (5 g daily), it will be effective in keeping body fat ratio and serum lipid levels normal and eliminating excessive lipids from the body. The changes in body fat ratio and serum lipids induced by the ingestion of beta-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of beta-conglycinin differed between students with a baseline body fat ratio over 25% and those less than 25%. In the former group, the ingestion of beta-conglycinin suppressed the increase in body fat ratio. Moreover the six subjects who had a high total cholesterol level (5.72 mmol/L or higher) tended to have reduced levels of serum triglyceride, free fatty acid, total cholesterol and lipoprotein (a) after the ingestion of beta-conglycinin, although those levels did not change significantly. The number of subjects was only six, therefore it was inferred that significant changes were not observed. Thus, ingestion of soybean beta-conglycinin suppressed the increase in body fat ratio in individuals with a high baseline body fat ratio and reduced relatively high serum levels of lipids. Those results suggest that if soybean beta-conglycinin is ingested continuously (5 g daily), it will be effective in keeping body fat ratio and serum lipid levels normal and eliminating excessive lipids from the body. The changes in body fat ratio and serum lipids induced by the ingestion of β-conglycinin were examined in 41 healthy female university student volunteers. The trend of change in body fat ratio following the ingestion of β-conglycinin differed between students with a baseline body fat ratio over 25% and those less than 25%. In the former group, the ingestion of β-conglycinin suppressed the increase in body fat ratio. Moreover the six sub-jects who had a high total cholesterol level (5.72 mmol/L or higher) tended to have reduced levels of serum triglyceride, free fatty acid, total cholesterol and lipoprotein (a) after the ingestion of β-conglycinin, although those levels did not change significantly. The number of subjects was only six, therefore it was inferred that significant changes were not observed. Thus, ingestion of soybean β-conglycinin suppressed the increase in body fat ratio in indi-viduals with a high baseline body fat ratio and reduced relatively high serum levels of lipids. Those results suggest that if soybean β-conglycinin is ingested continuously (5g daily), it will be effective in keeping body fat ratio and serum lipid levels normal and eliminating excessive lipids from the body |
| Author | Miyazaki, C Kohno, M Fukui, K Baba, T. (Fuji Oil Co. Ltd., Izumisano, Osaka (Japan). Hannan R and D Center) Ishinaga, M Ueda, A Hirotsuka, M |
| Author_xml | – sequence: 1 fullname: Baba, T. (Fuji Oil Co. Ltd., Izumisano, Osaka (Japan). Hannan R and D Center) – sequence: 2 fullname: Ueda, A – sequence: 3 fullname: Kohno, M – sequence: 4 fullname: Fukui, K – sequence: 5 fullname: Miyazaki, C – sequence: 6 fullname: Hirotsuka, M – sequence: 7 fullname: Ishinaga, M |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15596954$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15228214$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkUuP0zAQgC20iO0uXLiDfIEDUoqdOIl9RNXy0kpwgHM0ccatK9cutlMpN3466YMFIXywpfE332hmbsiVDx4Jec7ZsuJt-3br02FZs2XZPCILLiUv2laUV2TBKsYLIRm7JjcpbRkTSgr5hFzzuixlycWC_LwzBnVONBiawtQjeNpjhkIHv3aTtt56GuZYGCZqINMI2QYKfqAJ47ijzu7tQB0e0CU6sxsElzcTPQQ3-owYT2qDO3BIR28Pc8TmiaY8DuhzekoeG3AJn13eW_L9_d231cfi_suHT6t394WuW5kL0YJERMXnzgwa3jPdqx7LWmFjmFJDhSh6lKIXpqm1ka1WYgDG-dDXArG6Ja_P3n0MP0ZMudvZpNE58BjG1DXzEapsZvDlBRz7HQ7dPtodxKn7PbMZeHUBIGlwJoLXNv3F1apR9ZF7c-Z0DClFNH8Q1h0X1x0X19WsO1Vl_8Da5uOofY5g3f9TVueUbcqwxgc7xGy1wxPKVVsdcX6-yubhV28gduhny4uzxUDoYB3nTj5_LRmrGWONbKpfpUS_-w |
| CitedBy_id | crossref_primary_10_3177_jnsv_66_270 crossref_primary_10_1016_j_atherosclerosis_2007_01_037 crossref_primary_10_1007_s00394_013_0620_9 crossref_primary_10_12677_HJAS_2018_87122 crossref_primary_10_3136_fstr_FSTR_D_23_00047 crossref_primary_10_1007_s10681_006_9115_6 crossref_primary_10_1007_s11103_011_9865_y crossref_primary_10_1017_jns_2017_68 crossref_primary_10_1079_BJN20061776 crossref_primary_10_5551_jat_13_247 crossref_primary_10_4161_gmic_21578 crossref_primary_10_1039_c3fo30323c crossref_primary_10_1111_j_1750_3841_2006_00028_x crossref_primary_10_1093_jhered_esp046 crossref_primary_10_3390_nu8080491 |
| ContentType | Journal Article |
| Copyright | the Center for Academic Publications Japan 2004 INIST-CNRS |
| Copyright_xml | – notice: the Center for Academic Publications Japan – notice: 2004 INIST-CNRS |
| DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.3177/jnsv.50.26 |
| DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1881-7742 |
| EndPage | 31 |
| ExternalDocumentID | 15228214 15596954 10_3177_jnsv_50_26 article_jnsv1973_50_1_50_1_26_article_char_en JP2005000686 |
| Genre | Clinical Trial Randomized Controlled Trial Journal Article |
| GroupedDBID | --- -~X .55 .GJ 2WC 3O- 53G 5GY 5RE AAWTL AAYJJ ABIWU ADBBV AENEX AEQTP AI. ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DU5 F5P FBQ JSF JSH KQ8 OK1 RJT RYR RZJ TKC TR2 VH1 X7J X7M ZGI ZXP AABQG AAUGY AAFWJ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c578t-47a8eee91742fef1b0cb9be259e6f099d3ee4be84b4f65cf87c94da011db54ee3 |
| ISSN | 0301-4800 |
| IngestDate | Fri Jul 11 00:17:58 EDT 2025 Tue Aug 05 11:40:12 EDT 2025 Mon Jul 21 09:16:21 EDT 2025 Tue Jul 01 01:41:18 EDT 2025 Thu Apr 24 23:06:14 EDT 2025 Thu Aug 17 20:27:06 EDT 2023 Wed Dec 27 19:12:40 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Human Adipose tissue Anthropometry Lipids Corporal biometry Soybean Student Triglyceride Cholesterol Body composition Feeding β-conglycinin serum lipid Female body fat ratio |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c578t-47a8eee91742fef1b0cb9be259e6f099d3ee4be84b4f65cf87c94da011db54ee3 |
| Notes | S20 2005000686 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jnsv1973/50/1/50_1_26/_article/-char/en |
| PMID | 15228214 |
| PQID | 66664926 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_66664926 pubmed_primary_15228214 pascalfrancis_primary_15596954 crossref_primary_10_3177_jnsv_50_26 crossref_citationtrail_10_3177_jnsv_50_26 jstage_primary_article_jnsv1973_50_1_50_1_26_article_char_en fao_agris_JP2005000686 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2004-02-01 |
| PublicationDateYYYYMMDD | 2004-02-01 |
| PublicationDate_xml | – month: 02 year: 2004 text: 2004-02-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Tokyo |
| PublicationPlace_xml | – name: Tokyo – name: Japan |
| PublicationTitle | Journal of Nutritional Science and Vitaminology |
| PublicationTitleAlternate | J Nutr Sci Vitaminol |
| PublicationYear | 2004 |
| Publisher | Center for Academic Publications Japan |
| Publisher_xml | – name: Center for Academic Publications Japan |
| References | 4) Minami K, Moriyama R, Kitagawa K, Makino S. 1990. Identification of soybean protein components that mod-ulate the action of insulin in vitro. Agric Biol Chem 54: 511-517. 10) Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817. 8) Saito T, Kohno M, Tsumura K, Kugimiya W, Kito M. 2001. Novel method using phytase for separation soy-bean B-conglycinin and glycinin. Biosci Biotech Biochem 65: 884-887. 13) Sato H, Miyamoto S, Sasaki N, Niimi H. 1996. Seasonal variation of body composition assessed by bioelectrical impedance analysis in school children. Nihon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 100: 1459-1463 (in Japanese). 11) Kushner RE 1992. Bioelectrical impedance analysis: A review of principles and applications. J Am Coil Nutr 11: 199-209. 14) Ikeuchi T, Morimoto T, Nishikawa H. 1994. Seasonal change in body composition assessed by bioelectrical impedance method. Nihon Seikisho Gakkai Zasshi (Jpn J Biometeor) 31: 69-73 (in Japanese). 9) Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. 1986. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J AppI Physiol 60: 1327-1332. 5) Aoyama T, Kohno M, Saito T, Fukui K, Takamatsu K, Yamamoto T, Hashimoto Y, Hirotsuka M, Kito M. 2001. Reduction by phytate-reduced soybean β-conglycinin of plasma triglyceride level of young and adult rats. Biosci Biotech Biochem 65 : 1071-1075. 7) Kambara H, Baba T, Miyazaki C, Hirotsuka M, Kito M. 2003. A lowering effect of soybean β-conglycinin on β-body fat ratio in human. Ther Res 24: 861-866 (in Jap-anese). 2) Descovich GC, Ceredi C, Gaddi A, Benassi MS, Mannino G, Colombo L, Fontana G, Senin U, Mannarino E, Caruzzo C, Bertelli E, Fragiacome C, Noseda G, Sirtori M, Sirtori CR. 1980. Multicentre study of soybean pro-tein diet for outpatient hypercholesterolemic patients. Lancet 316: 709-712. 6) Kambara H, Hirotsuka M, Takamatsu K, Kito M. 2002. A lowering effect of soybean β-conglycinin on serum triglyceride level in humans. Ther Res 23: 85-89 (in Jap-anese). 1) Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effect of soy protein intake on serum lipids. N Engl J Med 333: 276-282. 15) U.S. Food and Drug Administration (FDA). Oct. 26, 1999. Food Labeling: Health claims, Soy protein and coronary heart disease; Final rule. Fed Regist 64 (206): 57700-57733. 16) Brooks JR, Morr CV. 1985. Current aspects of soy pro-tein fractionation and nomenclature. J Am Chem Soc 62: 1347-1354. 3) Kawamura S. 1997. Peptides from soybean globulins with the action to inhibit angiotensin-converting enzymes and their effects to blood pressure. Shokuhin Kogyo (Food Ind) 40: 73-82 (in Japanese). 12) Iritani N, Hosomi H, Fukuda H, Tada K, Ikeda H. 1996.Soybean protein suppresses hepatic hpogenic enzyme gene expression in Wistar fatty rats. J Nutr 126: 380-388. |
| References_xml | – reference: 8) Saito T, Kohno M, Tsumura K, Kugimiya W, Kito M. 2001. Novel method using phytase for separation soy-bean B-conglycinin and glycinin. Biosci Biotech Biochem 65: 884-887. – reference: 11) Kushner RE 1992. Bioelectrical impedance analysis: A review of principles and applications. J Am Coil Nutr 11: 199-209. – reference: 7) Kambara H, Baba T, Miyazaki C, Hirotsuka M, Kito M. 2003. A lowering effect of soybean β-conglycinin on β-body fat ratio in human. Ther Res 24: 861-866 (in Jap-anese). – reference: 12) Iritani N, Hosomi H, Fukuda H, Tada K, Ikeda H. 1996.Soybean protein suppresses hepatic hpogenic enzyme gene expression in Wistar fatty rats. J Nutr 126: 380-388. – reference: 14) Ikeuchi T, Morimoto T, Nishikawa H. 1994. Seasonal change in body composition assessed by bioelectrical impedance method. Nihon Seikisho Gakkai Zasshi (Jpn J Biometeor) 31: 69-73 (in Japanese). – reference: 3) Kawamura S. 1997. Peptides from soybean globulins with the action to inhibit angiotensin-converting enzymes and their effects to blood pressure. Shokuhin Kogyo (Food Ind) 40: 73-82 (in Japanese). – reference: 1) Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effect of soy protein intake on serum lipids. N Engl J Med 333: 276-282. – reference: 10) Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817. – reference: 15) U.S. Food and Drug Administration (FDA). Oct. 26, 1999. Food Labeling: Health claims, Soy protein and coronary heart disease; Final rule. Fed Regist 64 (206): 57700-57733. – reference: 5) Aoyama T, Kohno M, Saito T, Fukui K, Takamatsu K, Yamamoto T, Hashimoto Y, Hirotsuka M, Kito M. 2001. Reduction by phytate-reduced soybean β-conglycinin of plasma triglyceride level of young and adult rats. Biosci Biotech Biochem 65 : 1071-1075. – reference: 6) Kambara H, Hirotsuka M, Takamatsu K, Kito M. 2002. A lowering effect of soybean β-conglycinin on serum triglyceride level in humans. Ther Res 23: 85-89 (in Jap-anese). – reference: 2) Descovich GC, Ceredi C, Gaddi A, Benassi MS, Mannino G, Colombo L, Fontana G, Senin U, Mannarino E, Caruzzo C, Bertelli E, Fragiacome C, Noseda G, Sirtori M, Sirtori CR. 1980. Multicentre study of soybean pro-tein diet for outpatient hypercholesterolemic patients. Lancet 316: 709-712. – reference: 16) Brooks JR, Morr CV. 1985. Current aspects of soy pro-tein fractionation and nomenclature. J Am Chem Soc 62: 1347-1354. – reference: 13) Sato H, Miyamoto S, Sasaki N, Niimi H. 1996. Seasonal variation of body composition assessed by bioelectrical impedance analysis in school children. Nihon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 100: 1459-1463 (in Japanese). – reference: 4) Minami K, Moriyama R, Kitagawa K, Makino S. 1990. Identification of soybean protein components that mod-ulate the action of insulin in vitro. Agric Biol Chem 54: 511-517. – reference: 9) Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. 1986. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J AppI Physiol 60: 1327-1332. |
| SSID | ssj0049848 |
| Score | 1.7268928 |
| Snippet | The changes in body fat ratio and serum lipids induced by the ingestion of β-conglycinin were examined in 41 healthy female university student volunteers. The... The changes in body fat ratio and serum lipids induced by the ingestion of beta-conglycinin were examined in 41 healthy female university student volunteers.... |
| SourceID | proquest pubmed pascalfrancis crossref jstage fao |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 26 |
| SubjectTerms | Adipose Tissue Adult Antigens, Plant Biological and medical sciences BLOOD SERUM Body Composition - drug effects body fat ratio CHOLESTEROL Cholesterol - blood Diet Double-Blind Method FATS Fatty Acids, Nonesterified - blood Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Globulins - administration & dosage Glycine max - chemistry Humans LIPIDS Lipids - blood Lipoprotein(a) - blood MANKIND Placebos PROTEINS Seed Storage Proteins serum lipid Soybean Proteins - administration & dosage SOYBEANS Students triglviceride TRIGLYCERIDES Triglycerides - blood Vertebrates: anatomy and physiology, studies on body, several organs or systems β-conglycinin |
| Title | Effects of soybean beta-conglycinin on body fat ratio and serum lipid levels in healthy volunteers of female university students |
| URI | https://www.jstage.jst.go.jp/article/jnsv1973/50/1/50_1_26/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/15228214 https://www.proquest.com/docview/66664926 |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Nutritional Science and Vitaminology, 2004, Vol.50(1), pp.26-31 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZp9zIYY1vXzbt0gq2DEZw6tuzYsJekTUlTaPfQQN-MZUldmsQOtVPIHvaj9j-237QjyZekpOySBxEsWRY-n89FOheEPgQRo4wRZrY9yk2Qt44ZWNw3AV0crAEAEVfeFmfeYESGl-5lo_FzxWtpkdNW_G1jXMn_UBWuAV1llOw_ULaaFC7Af6AvtEBhaP-Kxv3aGSNLl1Ruqu8f9vd7tglW7tV0GcvqD_I4gKZs2RRR3lT0VgcGsMDFrDkdz8esOZWeQ8oxVodFLpuSacErl9G9MLngM5AjzUXtxJHplJjZPbptUub4L0Mui7CE23EezcbrW_m9bq-rUJNmX2W0la7EIntG_SPV0x1P0kownA_OzrW_P4zMo0klVo5Hp6OTItQoW0z42n4GKV2gS7cimYr0RvlYrkcIlM71Q1AikhUuCRzKJL5lrbJ0nct2DboFf_ZWJL0WP3dliKNPsa-T7LblWi17Q6LuOwK0cmuUR7xe4JIt9MAGq0UW1Dg6OS0VAxL4qphbtWKdLVc-76B-2pp-tCWiFFSjazAUZAaIR_Mogy9X6JIr99tESje6eIIeF4THXY3Qp6jBk2dop5tEeTpb4o9YuRkrou-g7wVocSpwAVr868cqYHGaYAlYDIDFCrAYsIMVYLECLNaAxTC2ACyuASsn1oDFNWBxCdjnaHTcvzgcmEUREDMGYZKbpBP5nPMALGdbcNGmVkwDysFq554A84Y5nBPKfUKJ8NxY-J04ICwCscWoSzh3dtF2kib8JcJxQKlwbAYaWZsIxnzCwXxwmM-ZcAPiGOhT-erDuMiQLwu1TEOwlCWZQkmm0LVC2zPQ-2rsXOeF2ThqFygYRlcgsMPhF7mDa6mgLAN91kStbi6YiLq5HXQcOUFbN7ZX9cpQTOB8Btpbg0K9hAKBBnpXYiMEeSEPAaOEp4ss9OAnk4Qa6IWGzMq9tu3bbfLqT5O_Rg_rD_cN2s5vFvwtqOY53VOA_w1B5_Ac |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+soybean+%CE%B2-conglycinin+on+body+fat+ratio+and+serum+lipid+levels+in+healthy+volunteers+of+female+university+students&rft.jtitle=Journal+of+nutritional+science+and+vitaminology&rft.au=BABA%2C+Toshimitsu&rft.au=UEDA%2C+Aiko&rft.au=KOHNO%2C+Mitsutaka&rft.au=FUKUI%2C+Kensuke&rft.date=2004-02-01&rft.pub=Center+for+Academic+Publications+Japan&rft.issn=0301-4800&rft.volume=50&rft.issue=1&rft.spage=26&rft.epage=31&rft_id=info:doi/10.3177%2Fjnsv.50.26&rft.externalDBID=n%2Fa&rft.externalDocID=15596954 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4800&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4800&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4800&client=summon |